Anti-Dxd [12G9-2]
AB04094-10.3-BT
ApplicationsELISA
Product group Antibodies
ReactivityOther Species
Overview
- SupplierAbsolute Antibody
- Product NameAnti-Dxd [12G9-2]
- Delivery Days Customer9
- Antibody SpecificityThis antibody binds Dxd, an anti-cancer alkaloid camptothecin analog, which is a potent DNA topoisomerase I (TOP1) inhibitor. By forming a stable ternary complex with TOP1 and DNA, it arrests the cell cycle to S phase, thereby preventing DNA replication a
- Application Supplier NoteThe binding reactivity of this antibody towards Dxd-KLH and Dxd-BSA conjugates was determined using ELISA. This antibody is capable of binding antibody-drug conjugates ADC-8201 and ADC029 in a competitive ELISA, wherein the antibody was trastuzumab. The binding affinity of this antibody towards Dxd-BSA was determined using surface plasmon resonance (SPR) and it was reported to be Kd= 3.38nM (CN115677857).
- ApplicationsELISA
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID12G9-2
- HostHuman
- IsotypeIgG1
- Scientific DescriptionThis is a reformatted human IgG1 Fc Silent™ antibody, based on the original human IgG1 format, created for improved compatibility with existing reagents, assays and techniques.
- ReactivityOther Species
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203